Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

This research was supported by Acción Transversal del Cáncer, approved by the Spanish Council of Ministeres on the 11th October 2007, by the Carlos III Health Institute-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/ 01662, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI11/01810, PI14/01219, PI11/02213, PIE16/00049, PI17/01179, PI17-00092); by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by the Spanish Ministry of Economy and Competitiveness through the Carlos III Health Institute (ISCIII)); by the ISCIII Red Temática de Investigación del Cáncer (RTICC) (RD12/0036/0036), by the European Commission (grants FOODCT-2006-036224-HIWATE) (...)
Hernández-García, M., Molina-Barceló, A., Vanaclocha-Espi, M., Zurriaga, Ó., Pérez-Gómez, B., Aragonés, N., Amiano, P., Altzibar, J.M., Castaño-Vinyals, G., Sala, M., Ederra, M., Martín, V., Gómez-Acebo, I., Vidal, C., Tardón, A., Marcos-Gragera, R., Pollán, M., Kogevinas, M., Salas, D.